ArticleArchives of medical science : AMS2016

Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.

Martin Šimkovič et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.